Melanoma Clinical Trials

Showing 1101-1120 of 1,292 trials

Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery

NCT01989559

This pilot clinical trial studies booster vaccination in preventing disease recurrence in previously vaccinated patients with melanoma that has been removed by surgery. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells. Giving booster vaccinations may make a stronger immune response and prevent or delay the recurrence of cancer.

Recurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more

National Cancer Institute (NCI)30 participantsStarted Oct 2002

Portland, Oregon, United States

COMPLETEDPhase 1/2

A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma

NCT00429312

The purpose of this research study is to find out whether JX-594 (Pexa-Vec) is safe and effective for treating surgically unresectable malignant melanoma.

Melanoma

Jennerex Biotherapeutics10 participantsStarted Mar 2007

Los Angeles, California, United States • Billings, Montana, United States • Greenville, South Carolina, United States

COMPLETEDPhase 1

Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma

NCT01462773

The purpose of this study is to determine the safety, tolerability and dose limiting toxicities (DLTs) of VELCADE when administered in combination with interferon-alpha-2b (IFN-α-2b) to patients with metastatic malignant melanoma.

Melanoma

Ohio State University Comprehensive Cancer Center16 participantsStarted Jan 2006

Columbus, Ohio, United States

Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery

A Study of Recombinant Vaccinia Virus to Treat Malignant Melanoma

Study of Patients With Stage IV Malignant Melanoma Using PS-341 (Bortezomib, Velcade) and Interferon-alpha-2b in Malignant Melanoma

Related Searches

Skin Cancer Screening and Education at Beaches

Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Autonomic Phenotype Before and After Akt Inhibition

Pilot Study of Infrared Imaging of Cutaneous Melanoma

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma

Partner Assistance in Learning and Performing Skin Self-Examination

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma

A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma

A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer